16-56498434-T-C

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBA1

The NM_031885.5(BBS2):​c.1659+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0066 in 1,613,902 control chromosomes in the GnomAD database, including 622 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.035 ( 325 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 297 hom. )

Consequence

BBS2
NM_031885.5 splice_region, intron

Scores

2
Splicing: ADA: 0.9914
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.65
Variant links:
Genes affected
BBS2 (HGNC:967): (Bardet-Biedl syndrome 2) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 16-56498434-T-C is Benign according to our data. Variant chr16-56498434-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 261980.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56498434-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.117 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS2NM_031885.5 linkc.1659+3A>G splice_region_variant, intron_variant Intron 13 of 16 ENST00000245157.11 NP_114091.4 Q9BXC9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS2ENST00000245157.11 linkc.1659+3A>G splice_region_variant, intron_variant Intron 13 of 16 1 NM_031885.5 ENSP00000245157.5 Q9BXC9
ENSG00000288725ENST00000684388.1 linkn.579+3A>G splice_region_variant, intron_variant Intron 4 of 13 ENSP00000507647.1 A0A804HJU2

Frequencies

GnomAD3 genomes
AF:
0.0347
AC:
5274
AN:
152112
Hom.:
322
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.119
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0146
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.0272
GnomAD3 exomes
AF:
0.00921
AC:
2314
AN:
251148
Hom.:
138
AF XY:
0.00655
AC XY:
889
AN XY:
135782
show subpopulations
Gnomad AFR exome
AF:
0.122
Gnomad AMR exome
AF:
0.00695
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000387
Gnomad OTH exome
AF:
0.00506
GnomAD4 exome
AF:
0.00367
AC:
5360
AN:
1461672
Hom.:
297
Cov.:
32
AF XY:
0.00316
AC XY:
2297
AN XY:
727144
show subpopulations
Gnomad4 AFR exome
AF:
0.121
Gnomad4 AMR exome
AF:
0.00778
Gnomad4 ASJ exome
AF:
0.00203
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000220
Gnomad4 FIN exome
AF:
0.0000375
Gnomad4 NFE exome
AF:
0.000301
Gnomad4 OTH exome
AF:
0.00850
GnomAD4 genome
AF:
0.0348
AC:
5294
AN:
152230
Hom.:
325
Cov.:
32
AF XY:
0.0339
AC XY:
2523
AN XY:
74420
show subpopulations
Gnomad4 AFR
AF:
0.120
Gnomad4 AMR
AF:
0.0145
Gnomad4 ASJ
AF:
0.00317
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000529
Gnomad4 OTH
AF:
0.0270
Alfa
AF:
0.00394
Hom.:
33
Bravo
AF:
0.0393
Asia WGS
AF:
0.00693
AC:
25
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

May 04, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 27894351, 27884173, 21642631) -

Jun 23, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
Jun 13, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Bardet-Biedl syndrome 1 Benign:2
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 23, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Bardet-Biedl syndrome 2 Benign:2
Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Bardet-Biedl syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
15
DANN
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Pathogenic
0.84
SpliceAI score (max)
0.69
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.69
Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6499838; hg19: chr16-56532346; COSMIC: COSV104392578; COSMIC: COSV104392578; API